Study of a combination of fenugreek/phaseolamin as a new weight loss agent

A pilot study to investigate the efficacy and tolerability of a combination of fenugreek/phaseolamin as a potential weight loss agent when given as part of a muesli bar in moderately obese patients

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12607000130460

Enrollment

Registered

2007-02-15

Start date

2007-03-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is looking at whether a new investigational product (a combination of fenugreek and phaseolamin in a muesli bar taken for 12 weeks) is effective at causing weight loss. Specific components in the blood are also measured to see if the product has any effect on them.

Interventions

Participants will receive one treatment three times a day (~20min before each meal) for twelve weeks: the treatment muesli bar containing Fenulife 43 (3g/bar) and phaseolamin (0.23g/bar).

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

25 Years to 60 Years

Healthy volunteers

Inclusion criteria

Overweight as defined by body mass index 30-40kg/m2Generally healthyWeight stable over previous 3 monthsWilling and able to give written informed consent.

Exclusion criteria

Diabetic (receiving pharmacological treatments for diabetes)Pregnant, breastfeeding, or intending to become pregnant during the studyAny medications, or medical conditions that might, in the opinion of the Principal Investigator, affect participant safety or outcomeCurrently on an alternative weight loss programme or planning to start a programme during the study durationHas a pace-makerPlanning international travel during the study.

Outcome results